Ablynx Competitors and Similar CompaniesClear all
Ablynx's competitors and similar companies include Innate Pharma and Genfit.
 Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. |  Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. |  Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. | |
Founding Date | Founding Date 2001 | Founding Date 1999 | Founding Date 1999 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Gent, BE HQ | Locations Marseille, FR HQ Rockville, US | Locations Loos, FR HQ Cambridge, US |
Employees | Employees 1252% decrease | Employees 181 | Employees 180 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 148.6 m | Valuation ($) 280.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) €2.8m (FY, 2025) | Revenue (est.) €65.4m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €266k (FY, 2025) | Cost of goods €302k (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €8.7m (FY, 2025) | Gross profit €70.8m (FY, 2025) |
Net income | Net income (€1.1m) (FY, 2016) | Net income (€49.2m) (FY, 2025) | Net income (€86m) (FY, 2025) |
Operating ⚠ | |||
Patents (Foreign) | Patents (Foreign) 180 (Q2, 2017) | Patents (Foreign) N/A | Patents (Foreign) 450 (FY, 2019) |
Patents (US) | Patents (US) 50 (Q2, 2017) | Patents (US) N/A | Patents (US) 28 (FY, 2019) |
Funding | |||
Total funding raised | Total funding raised $ 498.8m | Total funding raised $ 94.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Innate Pharma
HQ
Marseille, FR
Employees
181
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View companyGenfit
HQ
Loos, FR
Employees
180
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
View company